Share on StockTwits
 

PetMed Express (NASDAQ:PETS)‘s stock had its “neutral” rating reiterated by Zacks in a research report issued to clients and investors on Wednesday, AR Network reports. They currently have a $14.00 price objective on the stock. Zacks‘ price target suggests a potential upside of 4.01% from the stock’s previous close.

Zacks‘ analyst wrote, “PetMed’s EPS of $0.23 during the third quarter of fiscal 2014 were in line with the year-ago figure as well as the Zacks Consensus Estimate. Revenues were up 1% year over year to $50.1 million, but missed the estimate by 4%. Although we are encouraged by the company’s efforts to revive the topline, lower new order sales was a drag. Besides, increasing product costs and discounts laid huge pressure on margin. The company continues to face competitive pressure in the pet medications market. The dearth of any major near-term catalyst might make it difficult for PetMed to overcome these challenges in the near future. We are Neutral on the stock.”

PetMed Express (NASDAQ:PETS) traded down 0.89% during mid-day trading on Wednesday, hitting $13.34. The stock had a trading volume of 102,618 shares. PetMed Express has a 52-week low of $12.24 and a 52-week high of $17.75. The stock has a 50-day moving average of $14.26 and a 200-day moving average of $15.38. The company has a market cap of $265.8 million and a price-to-earnings ratio of 14.96.

PetMed Express (NASDAQ:PETS) last released its earnings data on Tuesday, January 21st. The company reported $0.23 earnings per share for the quarter, meeting the analysts’ consensus estimate of $0.23. The company had revenue of $50.10 million for the quarter, compared to the consensus estimate of $52.06 million. During the same quarter last year, the company posted $0.23 earnings per share. PetMed Express’s revenue was up 1.0% compared to the same quarter last year. On average, analysts predict that PetMed Express will post $0.90 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which is scheduled for Friday, February 21st. Stockholders of record on Wednesday, February 12th will be paid a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a dividend yield of 5.05%. The ex-dividend date is Monday, February 10th.

PetMed Express, Inc (NASDAQ:PETS) and its subsidiaries, doing business as 1-800-PetMeds, is a pet pharmacy.

To view Zacks’ full report, visit www.zacks.com

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.